Animal experiments showed that after administration of Klotho-derived peptides, the expression of β-catenin protein in the kidney of mice decreased, the levels of downstream fibrosis markers (such as α-SMA, collagen I) decreased significantly, and the glomerular sclerosis index and interstitial fibrosis score were improved. The gene discussed is KL; the disease is Glomerular sclerosis.